EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.3.1.93 | 3-methylbutyryl-CoA + 13-hydroxylupanine |
97% of activity compared to tigloyl-CoA |
Lupinus albus |
CoA + 13-(3-methylbutyryl)oxylupanine |
- |
ir |
2.3.1.93 | benzoyl-CoA + 13-alpha-hydroxymultiflorine |
- |
Lupinus albus |
CoA + 13-benzoyloxymultiflorine |
- |
? |
2.3.1.93 | benzoyl-CoA + 13-hydroxylupanine |
- |
Lupinus albus |
CoA + 13-benzoyloxylupanine |
- |
? |
2.3.1.93 | benzoyl-CoA + 13-hydroxylupanine |
111% of activity compared to tigloyl-CoA |
Lupinus albus |
CoA + 13-benzoyloxylupanine |
- |
ir |
2.3.1.93 | butyryl-CoA + 13-hydroxylupanine |
27% of activity compared to tigloyl-CoA |
Lupinus albus |
CoA + 13-butyryloxylupanine |
- |
ir |
2.3.1.93 | more |
- |
Lupinus albus |
? |
- |
? |
2.3.1.93 | more |
substrate specificity, overview |
Lupinus albus |
? |
- |
? |
2.3.1.93 | more |
lupinine, 4-hydroxylupinine, and cholesterol and acetyl-CoA are no substrates |
Lupinus albus |
? |
- |
? |
2.3.1.93 | more |
baptifoline, epilupinine and lupinine are no substrates |
Lupinus albus |
? |
- |
? |
2.3.1.93 | more |
control of quinolizidine alkaloid patterns in a tissue-specific manner |
Lupinus albus |
? |
- |
? |